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Yukari Takeno1*, Hiromi Arita2 and Etsuko Fujimoto1Abstract
Although complete decongestive therapy (CDT) is considered to reduce the volume of lymphedema, there is no
concrete evidence to sustain its efficacy. The purpose of the present study was to find new evidence of CDT based
on visualizing the changes of lymph fluid accumulating in an edematous limb using indocyanine green (ICG)
fluorescent lymphography in real time.Twelve lymphedema rats were divided randomly into two groups. On the
first day, ICG was injected into an edematous limb of rats, and no-intervention and CDT was applied to groups 1
and 2, respectively, for two weeks. ICG lymphography and circumferential measurements were done every two
days in each two-week observation. The results indicates that a fluorescent flow to the ipsilateral axillary fossa was
identified in all rats. In addition, network-like and dermal backflow patterns were observed in the lower legs and
thighs. While manual lymph drainage was applied in the CDT group, the flow moved more rapidly through this
pathway than that in the no-intervention group. An area of high-intensity fluorescent signals concentrated around
the injection sites diminished in the CDT group more than that in the no-intervention-group after two weeks.
Circumferential lengths of the edematous limbs were longer than the non-edematous limbs in both groups 1 and
2 on the day of ICG injection. The no-intervention group 1 showed no significance differences during 14 days,
whereas the CDT group 2 exhibited very significant differences. These results suggest that CDT has beneficial
effects in lymphedema treatment.Introduction
Lymphedema is a chronic inflammatory lymphostatic di-
sease caused by mechanical failure of the lymphatic
drainage system. According to a survey of characteristics
of lymphedema in a developed country, the majority of
the patients (80%) had cancer-related lymphedema, and
12% had non-cancer related lymphedema. Patients with
primary lymphedema were only 8% (Sitzia et al. 1998).
Especially, arm edema in women after axillary lymph
node dissection for breast cancer is common (Szuba and
Rockson 1998).
There are about 1.38 million new cases of breast can-
cer each year in major 184 countries (Ferlay et al. 2010).
Although not all breast cancer patients who take surgery
and/or radiation therapy develop secondary lymphedema,
it is one of the most troublesome and chronic longterm* Correspondence: takeno.yukari@a.mbox.nagoya-u.ac.jp
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in any medium, provided the original work is paftereffects of damage to the lymph nodes (Loprinizi et al.
1999). Thus, the demand for lymphedema treatment is
also expected to increase in the decade ahead.
Combined decongestive therapy (CDT) is an integral
method of conservative treatment to ease lymphedema.
Previous studies have tried to detect its efficacy in terms
of the volume reduction of an edematous limb (Koul
et al. 2007; Pinell et al. 2008) and an improvement in
quality of life (Mondry et al. 2004). However, the Inter-
national Society of Lymphology states that this therapy
has yet to undergo a sufficient meta-analysis of multiple
studies (International Society of Lymphology 2009). To
prove this, CDT has been still uncovered by government
insurance in many countries (Towers et al. 2008), and
patients with lymphedema can difficultly seek it at low
cost in public health service institutions. Therefore, a
different approach to examine CDT is sought so that
medical professionals can offer well-supported care to
lymphedema patients.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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been used to treat lymphedema along with the develop-
ment of a photodynamic eye system (PDE: Hamamatsu
Photonics K.K. Hamamatsu, Japan) (Ogata et al. 2007;
Unno et al. 2008). However, this novel method has yet
to be used as an assessment tool to test the efficacy of
CDT. Considering methodological difficulties and ethical
issues to conduct experimental research using humans
in lymphedema by ICG lymphography, the present study
used animals because the models are easy to access, and
also because it is possible to intervene during the study.
The purpose of the present study was to find new evi-
dence of CDT based on visualizing the changes of
lymph fluid accumulating in an edematous limb using
ICG lymphography.Materials and methods
Materials
Twelve male SPF Wistar rats (age range, 9–10 weeks;
Body weight 230~250 g) were used. The rats were pur-
chased from Japan SLC Company (Hamamatsu, Shizuoka,
Japan) and housed in groups of 2 per cage. Room tem-
perature and humidity was maintained at 26°C and
40–60%, respectively, and automatic light control was
set on 12:12-hr cycle. The rats could access to food
and water with ad libitum.
All in vivo experimental protocol were reviewed and
approved by the Animal Experiment Committee of
Nagoya University.Surgical procedure
During surgery, rats were maintained with approxima-
tely 1.6% isoflurane. The hind limbs were shaved toFigure 1 Schedule of group 1 & 2.measure a circumferential length at both groins. Then,
0.2 ml of a 100 mg/ml solution of Evans Blue (EB) dye
was injected subcutaneously into the dorsum of the right
paw and both the medial and the lateral ankles to detect
lymph nodes (LNs) and vessels. An incision from a sur-
face of the skin to subcutaneous tissue was made along
the right inguinal ligament. Lymph nodes with sur-
rounding adipose tissue in the inguinal site and in the
ipsilateral popliteal fossa were excised. Dyed lymph ves-
sels were carefully ligated under optical imaging by a
10–0 monofilament non-absorbed suture. Furthermore,
a dyed LN in the pelvis was excised. The skin edges were
sutured end to end by 4–0 nylon. No dressings or to-
pical treatments were applied to any of the wounds.
Analgesia and antibiotic was not given post operatively.
Rats wore an Elizabethan collar for three weeks after
surgery to prevent them from removing the sutures.Experimental schedule
Five weeks after lymphadenectomy, all rats were divided
randomly into two groups. An experimental protocol
of both groups consisted of three parts: a two-week-
observation, a one-week-interval, and a following two-
week-observation (Figure 1). On the first day of each
two-week observation period, 0.2 ml of a 1 mg/ml of ICG
was injected into the same spots used when lymph nodes
and vessels were dyed by EB. An observation by PDE was
then performed under given certain condition.
Circumferential lengths were also measured at the
proximal site of the incision line and at the untreated
contralateral thigh bilaterally with a tape measure. ICG
lymphography and circumferential measurements were
done every two days in each two-week observation.
Takeno et al. SpringerPlus 2013, 2:225 Page 3 of 6
http://www.springerplus.com/content/2/1/225Group 1 (n=6)
No intervention was applied in the first two weeks. After
the one-week interval, CDT was applied in the next two
weeks.
Group 2 (n=6)
Combined decongestive therapy was initially applied in
the first two weeks. After the one-week interval, no in-
tervention was applied in the next two weeks.
Procedure of CDT
Compression decongestive therapy consisted of manual
lymph drainage (MLD), during which a compression
bandage and exercise were used. Regarding MLD, only a
stationary circle was performed for 15 minutes on the
treated hind limb, the bilateral groins, and the right lat-
eral side of the abdomen toward an ipsilateral axillary
region from the right inguinal ligament. MLD was al-
ways done by the same person during the procedure.
Bandage compression was applied using a cotton ban-
dage for an under layer and a 1-cm–wide adhesive
elastic bandage for overlapping layers proceeding in a
proximal direction from the toe to the thigh. The rat
with the compression bandage was released into a cage
for two days. The rats could access to food and water
with ad libitum.
Data analysis
The images visualized by ICG lymphography were video-
recorded and compared between the pre- and each obser-
vation period.
Bilateral differences in lengths were presented as mean ±
standard divisions (SD). The significance of differences
was statistically analyzed with repeated measures by


















































Figure 2 The mean difference of circumferential lengths gradually de
significant differences between the day of ICG injection and days 6, 10, and
of ICG injection, (b) is on day 14 of no intervention period. (c) and (d) are oResults
Group 1
No intervention period
On the day of ICG injection, a high-intensity fluores-
cent signal was concentrated around the injection sites
(Figure 2a). In addition, network-like and dermal back-
flow patterns were identified in the lower legs and thighs
15 minutes after ICG injection. A fluorescent flow which
moved from the lower abdomen toward the ipsilateral
axillary fossa was observed in all the rats. Two of six rats
had another route to pass transversely through the
suprapubic region and then reach the contralateral in-
guinal fossa. A circumferential length of the treated hind
limb was longer than that of the untreated limb in all
rats. The mean ± SD between the limbs was 1.9 ± 0.54
centimeter (cm).
On day 2, the fluorescent pattern in the treated hind
limb changed slightly compared to the day of ICG injec-
tion. The concentration of the fluorescent signal around
the injection site was almost same as that on the day of
ICG injection, except that the network-like pattern ob-
served on the lower leg and thigh had disappeared.
Instead, a diffuse-like fluorescence signal was distribu-
ted unevenly in the whole of the treated hind limb.
No fluorescent flow to the ipsilateral axillary fossa
was detected.
From days 4 to 14, fluorescent images were almost
identical to those on day 2 (Figure 2b).
The mean ± SD in circumferential lengths between
the limbs was reduced for 14 days to 1.5 ± 0.41 cm.
There were no significant differences between the day of
ICG injection and days 6, 10, and 14 (Figure 2).
CDT period
On the day of ICG injection, a high-intensity fluores-
cent signal was concentrated around the injection sites(d)
ICGin Day6 Day10 Day14








creases during the first 2-week period. However, there are
14. Four photos are indicating the same hind limb. (a) is on the day
n the day of ICG injection and day 14 of CDT period, respectively.
Figure 3 Flourescent flows to the ipsilateral axillary fossa and
the contralateral inguinal fossa are clearly observed (left).
On day 2, the route to the ipsilateral axillary fossa blurry but still
observable after MLD are applied (right).
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flow patterns were identified in the lower leg and thigh
15 minutes after ICG injection. A fluorescent flow to the
ipsilateral axillary fossa was also observed in all the rats.
Another route to the contralateral inguinal fossa was ob-
served in two of them. While MLD was applied, the flow
moved rapidly along this pathway. However, the area of
the fluorescent signal in the treated hind limb did not
noticeably change before and after MLD by PDE obser-
vation. The mean ± SD in circumferential lengths be-
tween the limbs was 1.7 ± 0.2 cm.
On day 2, the fluorescent pattern in the treated hind
limb changed slightly compared to the day of ICG injec-
tion. The concentration of the fluorescent signal around
the injection site was almost the same as on the day of
ICG injection, but the network-like pattern observed on
the lower leg and thigh had disappeared. Instead, a
diffuse-like fluorescence signal was distributed unevenly
in the whole of the treated hind limb. The route to the
ipsilateral axillary fossa was blurry but still observable





















































Figure 4 The mean difference of circumferential lengths rapidly decre
between the day of ICG injection and day 6, 10 and 14. However, there are
indicating the same hind limb. (a) is on the day of ICG injection, (b) is on d
day 14 of no intervention period, respectively.Unlike the no intervention period, the fluorescent
signal around the injection sites diminished gradually
during the day from 4 to 14 (Figure 2d). On day 14, the
mean ± SD among the limbs was 0.35 ± 0.14 cm. There
were significant differences between the day of ICG in-
jection and days 6, 10, and 14 (Figure 2).Group 2
CDT period
On the day of ICG injection, a concentration of the
fluorescent signal around the injection sites was ob-
served (Figure 4a). A high-intensity fluorescent signal
was distributed from the foot pad to the ankle. In the
lower leg and the thigh, network-like and dermal back-
flow patterns such as stardust were observed for least 15
minutes. A fluorescent flow that moved from the lower
abdomen toward the ipsilateral axillary fossa appeared in
all the rats. One of them had another route to the con-
tralateral inguinal fossa. A circumferential length of the
treated hind limb was notably longer than that of the
untreated limb. The mean ± SD between the limbs was
1.62 ± 0.32 cm.
On day 2, the concentration of the signal around the
injection site was almost the same as on the day of ICG
injection, but the dermal backflow patterns on the lower
leg and thigh had disappeared. Instead, a fluorescent sig-
nal was distributed diffusely and unevenly in the whole
of the treated hind limb. The shape of the route to the
ipsilateral axillary fossa was ambiguous (Figure 3).
On day 14, the fluorescent signal around the injection
sites had decreased in comparison with day 2 (Figure 4b).
The mean ± SD in the lengths also diminished to
0.27 ± 0.2 cm. There were significant differences between
the day of ICG injection and days 6, 10, and 14 (Figure 4).ICGin Day6 Day10 Day14





ases during the first 2-week. There are significant differences
no significant differences during the second 2-week. Four photos are
ay 14 of CDT period. (c) and (d) are on the day of ICG injection and
Takeno et al. SpringerPlus 2013, 2:225 Page 5 of 6
http://www.springerplus.com/content/2/1/225Interval
A difference in circumferential lengths increased during
one week. After a t-test, the difference was significant
one (Figure 4).
No intervention period
On the day of the ICG injection, a concentration of
the fluorescent signal around the injection sites was ob-
served (Figure 4c). A high-intensity fluorescent signal
was distributed from the foot pad to the ankle. In the
lower leg and thigh, network-like and dermal backflow
patterns such as stardust were observed for least 15 mi-
nutes. A fluorescent flow which moved from the lower
abdomen toward the ipsilateral axillary fossa appeared
in all rats. A circumferential length of the treated
hind limb was longer than that of the untreated limb.
The mean ± SD between the limbs was 0.93 ± 0.31 cm.
The concentration of the fluorescent signal around the
injection sites changed little for 14 days in comparison
to that in the CDT period (Figure 4d). The mean ± SD
in lengths between the limbs increased slightly to 1.05 ±
0.31 cm in comparison with the day of the ICG injec-
tion. However, there were no significant differences be-
tween the day of the ICG injection and days 6, 10, and
14 (Figure 4).
Comparison between groups 1 and 2
During the first two-week period of both groups, no
intervention for group 1 and CDT for group 2 were
compared.
The fluorescent images observed on the day of ICG in-
jection were almost identical between groups. The fluo-
rescent flow to the ipsilateral axillary fossa was identified
in all rats. However, while MLD was applied in group 2,
the flow moved more rapidly through this pathway than
that in group 1.
The fluorescent signal concentrated around the injec-
tion sites decreased for 14 days in groups 1 and 2. How-
ever, a weaker signal was detected in the CDT group
(Figure 4a, b) than that in the no-intervention group
(Figure 2a, b).
Circumferential lengths of the treated hind limb were
longer than untreated limbs in both groups 1 and 2
on the day of ICG injection. Group 1 (no intervention)
showed no significance differences during 14 days, where-
as group 2 (CDT) exhibited significant differences.
Discussion
The fluorescent signal presented with a network-like
pattern in the treated hind limb travelled beyond the in-
cision line, where it became a linear pattern at the right
lateral region of the abdomen reaching to the right
axilla. The network-like and linear patterns represent
lymph capillaries and collectors, respectively. Therefore,lymph fluid that drained from the periphery by CDT
moved through lymph capillaries, flowed into lymph col-
lectors, and then reached the axillary LN. A reduction of
an edematous limb by an application of CDT has been
well-documented (Koul et al. 2007; Pinell et al. 2008).
However, pathways of lymph fluid and destination LNs
have never been studied scientifically. The present study
revealed drainage routes of lymph fluid in a lower limb
lymphedema.
The PDE system captured the high-intensity area of a
fluorescent signal around the injection site after ICG
was injected into the subcutaneous space of the right
paw and ankle. After CDT was applied for two weeks,
the high-intensity area at the injection site was reduced,
and the low-intensity fluorescent signal was increased
instead. These changes indicated that the application of
CDT to the edematous limb encourages lymph fluid to
move from the periphery. This is the first demonstration
that the efficacy of CDT has been visualized. ICG is less
invasive, and its fluorescent navigation is very sensitive.
The detection rates of sentinel LNs and lymphatic chan-
nels are 94~97% (Hirche et al. 2010; Kitai et al. 2005) and
100% (Abe et al. 2011; Kitai et al. 2005), respectively.
In both groups, the high-intensity area of the fluores-
cent signal was reduced after the 2-week-CDT, but there
was little reduction without CDT for another 2 weeks.
The changes in fluorescent images were well-supported
by the changes in circumferential lengths, thus rendering
the evidence becomes clearer than ever before. Each as-
sessment method has several weak points. The present
study offers a new experimental method that compen-
sates for the weaknesses of CDT research.
The efficacy of CDT was studied using lymphedema
rats in the present study. This experimental model is far
only for early edema but not acute postoperative edema.
Although the swelling occurs after surgical invasion in
the acute period, it improves over several days after sur-
gery. Rats used in the present study showed images indi-
cated as lymphedema by ICG lymphography at the
beginning of the experimental schedule between five and
seven weeks after lymphadenectomy. This may show
sustained lymphedema after acute postoperative edema
disappear.
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